Skip to main content

Kaposi's Sarcoma News

Related terms: Cancer, Kaposi's Sarcoma

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Pomalyst (pomalidomide) for AIDS-Related and HIV-Negative Kaposi Sarcoma

PRINCETON, N.J.--(BUSINESS WIRE)--May 15, 2020 – Bristol Myers Squibb (NYSE: BMY) today announced that Pomalyst ® (pomalidomide) was approved by the U.S. Food and Drug Administration (FDA) for ...

Ask a question

To post your own question to this support group, sign in or create an account.